Member Info for J_CIT

He needs to go and be replaced by someone of Polygons chosing. If they arent going to try and commercialise this drug in 2022, we need a vote of no confidence in RM

They won't have £25m for long when they try to run a large trial spread over 15 solar systems with 56 end points.

IMO:
- Synairgen won't be releasing any deep dive data via an RNS. They've alerted the market to information that may be market sensitive so have done their job. It will be disclosed to a larger bunch of scientists prior to investors.

- There will 100% be a placing announced at the end of May at a price of circa 15p a share (based on today's price) to fund running a new trial. Potentially even cheaper to attract investment. That's the only time they seem to care about investors.

- The proactive tweet got pulled yesterday. The interview with RM will be purely based around this meeting of minds with empty pockets.

- RM still is yet to grow a pair of danglies with the signing off comment that a general company update will be provided 25th May

Wish I cashed out at 200p as this company will never get close to that again. Break even at £1 so sticking around until then... if we get there.

My Sentiment exactly.

However, we fully know that Synairgen will not be entertaining the idea of any such EUA and will be still changing their P!55 ridden bed sheets.

They needed a head of commercial after PH2 success but again, poor leadership from RM.

And every RNS since top line data has mentioned further trials. No EUA will happen

Synairgen will NOT go for EUA. They haven't hinted at it and have reiterating in all recent RNSs that they will be pursuing larger platform trials.

The reason they will not attempt EUA is that the scientists here have their heads too deeply inserted into their colon to understand that this company, or any company, can run for years on £0 revenue. They will pursue scientific infallibility rather than spin the wheel for approval based on 40% reduction in death.

Its evident they haven't got a plan

If you’re not the best, then be the first.

We are neither

If we are paying 200k a year for our CEO to even begin to understand deep dive data then we need to give our heads a wobble.

He needs to be getting infront of people and trying to sell the dead horse to the highest bidder

If you defend RM here then you are honestly daft.

Six figure salary
Six figure bonus
Tonnes of shares
Sold everyone the dream for £85m a year ago

It is time to face whatever music is waiting for him.

One question; if the board had lined up a replacement with commercial experience of bringing a product to market and had big pharma ties, would you call for RM to stay?

Can't sell because I'm bag holdings but I'm not parting with another penny unless RM resigned and a CEO with a proven record of commercialising a product come on board.

They haven’t even suggested they will - they have repeatedly banged the drum of another trial.

Pretty obvious that is where they are headed, very much to our demise

Synairgen also said they had been asked to temp stop working on A2 a couple of weeks ago!

NIH may be working with them, until they arent

Great post. Look forward to seeing the analysis around 3 months after everyone stops caring about covid. Then we can do a placing to raise money to do a trial to recruit people who arent getting sick fast enough for anyone to care.

We struggle to recruit 600 patients globally in a year. Now covid is milder then we could spend 5 years trying but hey ho, think of the science

We should have applied for EUA on the back of 36% death reduction in ph3

Absolute slam dunk

But no, the company is more interested in working towards scientific infalibility rather than actually making money and surviving

Come off it lad - nothing positive in that

-P3 missed end points
-A2 cancelled
- A2 results not due for 3-4months
- Sprinter deep dive to be done ALONGSIDE A2 data
- Likely A2 and Sprinter feedback circa September to us
- SP of roughly fu&k All until then
- Noone will care about covid then so SP will remain fu&k all
- Synairgen delists and they all p!ss off back to the classroom

Yours sincerely
LTH

It doesn't say paused - No RNS has ever mentioned this 'sub' trial.

Imagine they figured out all the deaths were from 1 or 2 countries that used an alternative SoC.

Is this a parody?